APN Capstone Portfolio Part 2 NR661 APN Capstone Practicum

APN CAPSTONE PORTFOLIO PART 2 Capstone Portfolio Part 2 NR661 APN Capstone Practicum October 2020 1 APN CAPSTONE PORTFOLIO PART 2 Table of Contents Exemplar 1 …………..………………………………………………..…..………………3 Exemplar 2 …………..………………………………………………..…..………………8 Exemplar 3 …………..………………………………………………..…..……………..14 Exemplar 4 …………..………………………………………………..…..…………..…18 Exemplar 5 …………..………………………………………………..…..…………..…22 Exemplar 6 …………..………………………………………………..…..……………..25 Exemplar 7 …………..………………………………………………..…..…………..…29 Exemplar 8…………..………………………………………………..…..……………...32 Exemplar 9 …………..………………………………………………..…..…………..…36 Exemplar 10 …………..………………………………………………..…..……………41 References…………………………………….………………………………..………...47 Appendix A: Table of Exemplars…..…………………………………………….……...59 Appendix B: Concept Map……..……………………………………………….……….60 2 APN CAPSTONE PORTFOLIO PART 2 APN Capstone Portfolio Part 2 Chamberlain University has provided me the tools to successfully become a masters prepared Advanced Practice Nurse allowing me to build on my ever-growing professional knowledge base. Completing this portfolio allows me to consider my proficiency with the program outcomes (PO), the National Organization of Nurse Practitioner Faculties core competencies (NONPF) and the MSN Essentials. My collection of projects will display my growth both as a student and a professional throughout the program via the demonstrated Exemplars and how they relate with the MSN Essentials and Program Outcomes. Exemplar 1: NR503 Population Health, Epidemiology, & Statistical Principles: Analysis of MRSA Two type of MRSA exist; HA-MRSA (hospital acquired MRSA) and CA-MRSA (community acquired MRSA). HA-MRSA is the most common infection as MRSA is associated with invasive devices or procedures, surgeries, IV tubing or artificial joints (Mayo Clinic, 2018). CA-MRSA can occur amongst healthy people and often starts as a painful skin boil spread via skin-to-skin contact (Mayo Clinic, 2018). Populations at risk include members of sports teams, childcare workers and people who live in close contact in crowded conditions. MRSA is caused by staph bacteria that is normally found on skin or in the nose. This bacterium is typically harmless unless it enters the body via a wound but is generally a minor integumentary issue. Symptoms include skin that is warm to touch, swollen red abscesses that are painful and may be full of drainage while associated with a fever. Bacteria traveling past the skin can cause life-threatening infections within the 3 APN CAPSTONE PORTFOLIO PART 2 bloodstream, bones, and surgical wounds (Mayo Clinic, 2018). Treatment is often problematic as MRSA has evolved due to years of needless antibiotics prescribed for colds and viral infections. Fortunately, MRSA still responds to certain antibiotics and sometimes a simple incision and drainage procedure of the abscess may be all that is required (Mayo Clinic, 2018). The CDC (2014) identify determinants of health as sex and age, individual behavior, social and physical environments. Poor personal hygiene (high risk for infection from one’s own colonized strain) and compromised skin and/or immunocompromised systems can also increase the risk. Many groups have a higher probability of infection including the elderly, children, IV drug users, athletes, military personnel, homosexual men, and patients with underlying diseases or indwelling medical devices (Otto & Chatterjee, 2013). CA-MRSA is onset of infection within 49 hours of hospital admission without previous history in the previous year whereas HA-MRSA is the onset of infection after 48 hours of hospital admission (Otto & Chatterjee, 2013). The epidemiological triad consists of the host, the agent, and environmental factors. According to Guillamet, et al. (2017), host factors also have the greatest influence the mortality rates (short, medium, and long-term) of patients with MRSA. Acute and chronic factors affect mortality including the age of the patient, comorbidities such as liver disease and length of therapy all have a major impact on the mortality rates of patients being treated for MRSA (Guillamet, et al., 2017). Age can determine if a patient (host) succumbs to the infection process. The older patient population are at a higher risk as their white blood cell response is not as vigorous with an aging immune system (Guillamet, et al., 2017). MRSA is opportunistic and a 4 APN CAPSTONE PORTFOLIO PART 2